GL Biochem (Shanghai): difference between revisions
Diff·revision 51 → 52·22:52, 9 May 2025
Difference between revision 51 and revision 52 of GL Biochem (Shanghai). 4 lines changed; the page grew by 250 bytes.
| Revision 51 — 18:35, 29 Apr 2025 BetaCellBoyd (talk) convert prose to table for comparability 11,870 bytes ±0 | Revision 52 — 22:52, 9 May 2025 LedeLeander (talk) label community tally as self-reported 12,120 bytes +250 | ||
|---|---|---|---|
| 92 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 92 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| 93 | 93 | ||
| + | 94 | == Further reading == | |
| + | 95 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 96 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 97 | ||
| 94 | == See also == | 98 | == See also == |
| 95 | * [[Certificate of analysis]] | 99 | * [[Certificate of analysis]] |